In an April 2010 article by Nicolas Now, however, with the combined Basta writing for Pharmaceutical impact of the global recession on the Commerce it was estimated that in 2011 shipping industry during 2007 and 2008 $6.6B would be spent shipping and the double—digit growth and temperature-sensitive biological globalization of the life sciences materials to destinations all over the industry, there has been an escalation of world, and that the demand for global interest in the global transportation of cold chain logistics will grow at the biomaterials by  carriers that in the past same double-digit trajectory as the life played mostly an accidental role. sciences industry.

The increase in size and scale of bio-processing is presenting a new challenge. Traditional methods of sterilisation, to maintain clean facilities, are becoming difficult to deploy in a controlled and regulatory compliant way. By Richard Lucas, Ph.D., Bioquell UK Ltd.

A particle counter is an electronic instrument that detects and counts airborne or liquid particles. Particles are detected using laser based optical systems that shine a powerful light through a detection chamber. By Dr. Hans-Walter Motzkus and Joe Gecsey

The majority of pharmaceutical products have to enter the blood stream in order to be effective. They can be taken orally, via the intestine, by injection or infusion. By Uwe Amann

Just like mobile phones Handheld Particle Counters were originally quite large and heavy instruments that were not really very convenient to use, and due to the short battery life would run out at the most inconvenient moment! However, things have changed and happily we now have a great choice of many lightweight instruments with a wide range of features. By Dr. Hans-Walter Motzkus and Joe Gecsey

We have created a detailed brochure which depicts the Upstream Process Suite with Sartorius equipment, various bioprocessing applications and encompasses the features and benefits of using FlexMoSys compared to traditional and other builds.

In the years 1996 to 2003 the number of NMEs approved by the FDA thus halved, while the research expenditure in the same period almost doubled. Only roughly one in 5000 researched substances can be developed into a new drug. By Uwe Amann

Actions to increase awareness of green processes. By Ronald Gebhard, PhD, Director of R&D

Following the major earthquake (8.9 on Richter scale) that struck Japan on March 11, 2011, the Fukushima Daiichi nuclear plant suffered severe damage to multiple reactors. Due to the damage at the nuclear plant and other serious damage caused by the tsunami, service to the main cities and prefectures in central Japan was dramatically curtailed.

Nearly all drug substance and drug product CMOs have moved to a working system that uses dedicated project managers.